Infusion therapy is when medication is administered through a needle or catheter and is often prescribed when someone’s condition is so severe that oral medication cannot effectively treat the condition, such as cancers, blood disorders, autoimmune diseases, and infections.
Infusion therapy can be conducted in various settings:
- Clinics – Clinic infusions may take place in a dedicated center or a physician’s office.
- Homes – Patients may choose to have their infusion therapy administered in their home by registered nurses and pharmacists, directed by a physician. This service may be referred to as an Ambulatory Infusion Suite (AIS) of the home infusion therapy provider.
- Hospitals – Infusion services can be delivered in an inpatient or outpatient setting, including cancer centers and ambulatory infusion clinics.
- Ambulatory Surgery Centers (ASC) – Facilities that provide same-day surgery care, including diagnostic and preventive procedures, can also administer infusion therapy services.
- Mixed Mode – Combination of settings.
We calculated the median payments for one unit of a drug and its administration, for four high cost, high utilization infusion therapy services:
|J1569||Gammagard Liquid Injection (500 mg)||Gammagard Liquid®||Protects against infection in immune system disorders|
|J1745||Infliximab Injection||Remicade®||Minimizes inflammation|
|J7120||Ringers Lactate Infusion (up to 1000 cc)||Restores fluids and electrolytes|
|J9310||Rituximab Injection (100 mg)||Rituxan®||Treats cancer|
This display shows median payments statewide across all insurers for infusion therapy services administered from July 1, 2017 – June 30, 2018. Information on the uninsured or public payers Medicare and Medicaid (MaineCare) are not included. The Procedure Count is the number of times the drug was administered and the Provider Count is the number of facilities that administered the drug.
The costs for infusion therapy services varies across settings. Regardless of your health insurance, talk with your health care provider to see if receiving infusion therapy in a less expensive setting is an option.